Report cover image

Russia Generics Market Summary, Competitive Analysis and Forecast to 2027

Publisher MarketLine
Published Jul 21, 2023
Length 47 Pages
SKU # MTLN18195652

Description

Russia Generics Market Summary, Competitive Analysis and Forecast to 2027


Summary

Generics in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
  • The Russian generics market had total revenues of $11.9 billion in 2022, representing a compound annual growth rate (CAGR) of 11.6% between 2017 and 2022.
  • Market consumption volume increased with a CAGR of 3.5% between 2017 and 2022, to reach a total of 78.1 % in 2022.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 9% for the five-year period 2022 - 2027, which is expected to drive the market to a value of $18.3 billion by the end of 2027.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Russia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Russia
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Russia generics market with five year forecasts
Reasons to Buy
  • What was the size of the Russia generics market by value in 2022?
  • What will be the size of the Russia generics market in 2027?
  • What factors are affecting the strength of competition in the Russia generics market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Russia's generics market?

Table of Contents

47 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Krka, d. d., Novo mesto
8.2. Teva Pharmaceutical Industries Limited
8.3. Abbott Laboratories
8.4. Sanofi SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Russia generics market value: $ million, 2017-22
Table 2: Russia generics market volume: %, 2017-22
Table 3: Russia generics market geography segmentation: $ million, 2022
Table 4: Russia generics market value forecast: $ million, 2022-27
Table 5: Russia generics market volume forecast: %, 2022-27
Table 6: Krka, d. d., Novo mesto: key facts
Table 7: Krka, d. d., Novo mesto: Annual Financial Ratios
Table 8: Krka, d. d., Novo mesto: Key Employees
Table 9: Krka, d. d., Novo mesto: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Abbott Laboratories: key facts
Table 14: Abbott Laboratories: Annual Financial Ratios
Table 15: Abbott Laboratories: Key Employees
Table 16: Abbott Laboratories: Key Employees Continued
Table 17: Sanofi SA: key facts
Table 18: Sanofi SA: Annual Financial Ratios
Table 19: Sanofi SA: Key Employees
Table 20: Sanofi SA: Key Employees Continued
Table 21: Russia size of population (million), 2018-22
Table 22: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 23: Russia gdp (current prices, $ billion), 2018-22
Table 24: Russia inflation, 2018-22
Table 25: Russia consumer price index (absolute), 2018-22
Table 26: Russia exchange rate, 2018-22
List of Figures
Figure 1: Russia generics market value: $ million, 2017-22
Figure 2: Russia generics market volume: %, 2017-22
Figure 3: Russia generics market geography segmentation: % share, by value, 2022
Figure 4: Russia generics market value forecast: $ million, 2022-27
Figure 5: Russia generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Russia, 2022
Figure 7: Drivers of buyer power in the generics market in Russia, 2022
Figure 8: Drivers of supplier power in the generics market in Russia, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Russia, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Russia, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Russia, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us